Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | CGON | LGND | ||
| Company | Apellis Pharmaceuticals Inc | Cg Oncology Inc | Ligand Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 41.05 | 60.12 | 254.26 | ||
| High | 41.07 | 61.27 | 257.33 | ||
| Low | 41.03 | 59.42 | 253.35 | ||
| Latest | 41.03 | 59.66 | 255.90 | ||
| Change | -0.03 | +0.10 | +0.36 | ||
| % Change | -0.07% | +0.17% | +0.14% | ||
| Volume | 68,611,400 | 336,280 | 66,674 | ||
| 20-Day Average Volume | 7,541,190 | 916,889 | 198,033 | ||
| Previous Close | 41.06 | 59.56 | 255.54 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 40.97 | 59.36 | 234.36 | ||
| 20-Day Raw Stochastic | 67.65% | 44.33% | 92.85% | ||
| 20-Day Relative Strength | 81.66 | 46.52 | 67.55 | ||
| Weighted Alpha | +25.64 | +89.10 | +113.49 | ||
| Today's Opinion | 100% Buy | 24% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 8% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.22% since 05/06/26 | +9.49% since 06/08/26 | +7.33% since 06/08/26 | ||
| Low | 40.98 on 05/07/26 | 54.10 on 06/09/26 | 237.00 on 06/09/26 | ||
| High | 41.08 on 05/12/26 | 61.27 on 06/15/26 | 259.03 on 06/12/26 | ||
| 1-Month | |||||
| %Chg | +0.47% since 04/13/26 | -11.01% since 05/15/26 | +19.68% since 05/15/26 | ||
| Low | 40.78 on 04/14/26 | 53.21 on 06/08/26 | 205.19 on 05/19/26 | ||
| High | 41.14 on 05/06/26 | 67.54 on 05/18/26 | 259.03 on 06/12/26 | ||
| 3-Month | |||||
| %Chg | +89.08% since 02/13/26 | -7.36% since 03/13/26 | +25.76% since 03/13/26 | ||
| Low | 16.83 on 03/30/26 | 53.21 on 06/08/26 | 188.67 on 03/30/26 | ||
| High | 41.14 on 05/06/26 | 75.50 on 05/14/26 | 259.03 on 06/12/26 | ||
| 6-Month | |||||
| %Chg | +107.12% since 11/13/25 | +49.84% since 12/15/25 | +32.30% since 12/15/25 | ||
| Low | 16.83 on 03/30/26 | 37.01 on 12/17/25 | 175.89 on 01/13/26 | ||
| High | 41.14 on 05/06/26 | 75.50 on 05/14/26 | 259.03 on 06/12/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 5,252,701 | 5,253,311 | 5,121,277 | ||
| Shares Outstanding, K | 128,021 | 88,202 | 20,041 | ||
| Annual Sales | 1,003,780,000 | 4,040,000 | 268,090,000 | ||
| Annual Net Income | 22,390,000 | -161,000,000 | 124,450,000 | ||
| Last Quarter Sales | 268,300,000 | 1,080,000 | 51,720,000 | ||
| Last Quarter Net Income | 18,660,000 | -60,200,000 | -13,350,000 | ||
| 60-Month Beta | -0.24 | 0.31 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 05/07/26 | -0.71 on 05/08/26 | 1.63 on 05/07/26 | ||
| Earnings Date | 07/30/26 | 08/14/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | 2.500 on 04/03/07 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 40.25 | 0.00 | 34.54 | ||